![COMPOSITIONS AND METHODS FOR LIVE, ATTENUATED ALPHAVIRUS FORMULATIONS](/ep/2016/01/20/EP2968515A1/abs.jpg.150x150.jpg)
基本信息:
- 专利标题: COMPOSITIONS AND METHODS FOR LIVE, ATTENUATED ALPHAVIRUS FORMULATIONS
- 专利标题(中):组合物和方法减毒活甲病毒制剂
- 申请号:EP14717940.2 申请日:2014-03-13
- 公开(公告)号:EP2968515A1 公开(公告)日:2016-01-20
- 发明人: STINCHCOMB, Dan T. , LIVENGOOD, Jill A. , VARGA, Laszlo
- 申请人: Takeda Vaccines, Inc.
- 申请人地址: One Takeda Parkway Deerfield, IL 60015 US
- 专利权人: Takeda Vaccines, Inc.
- 当前专利权人: Takeda Vaccines, Inc.
- 当前专利权人地址: One Takeda Parkway Deerfield, IL 60015 US
- 代理机构: Vossius & Partner Patentanwälte Rechtsanwälte mbB
- 优先权: US201361784122P 20130314
- 国际公布: WO2014151855 20140925
- 主分类号: A61K39/12
- IPC分类号: A61K39/12
摘要:
Embodiments herein relate to compositions of and methods for live attenuated alphaviruses. In certain embodiments, a live, attenuated virus composition includes, but is not limited to, one or more live, attenuated alphaviruses and compositions to reduce inactivation and/or degradation of the live, attenuated alphavirus. In other embodiments, the live, attenuated virus composition may be a vaccine composition. In yet other compositions, a live, attenuated alphavirus composition may include HEPES buffer. In other embodiments, the HEPES buffer may further include a carbohydrate and gelatin and/or a salt.
公开/授权文献:
IPC结构图谱:
A | 人类生活必需 |
--A61 | 医学或兽医学;卫生学 |
----A61K | 医用、牙科用或梳妆用的配制品 |
------A61K39/00 | 含有抗原或抗体的医药配制品 |
--------A61K39/12 | .病毒性抗原 |